Why is CorMedix stock crashing today: is it worth buying on the dip?

Core Viewpoint - Investors are withdrawing from CorMedix (NASDAQ: CRMD) following the company's guidance of up to $320 million in revenue for fiscal 2026, which has not been well received by shareholders [1] Company Summary - CorMedix has projected revenue of up to $320 million for fiscal 2026, indicating a significant financial outlook [1]